In contrast, treatment of HNSCC cell lines with EMT-inducing concentrations of EGF and equimolar amounts of EpEX blocked EMT through decreased Erk1/2 activation [143]. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.